XLV241129P133000
- 0.00
- 0.000.00%
The Health Care Select Sector SPDR® Fund Newsroom
After Trump's nomination of the FDA commissioner, the supplier of "affordable weight loss drugs" Hims & Hers surged over 20%, reaching an all-time high.
"Hunterbrook Media, the institution that benchmarks against short sellers like Citron, believes that Trump's nomination of Marty Makary as the head of the usa Food and Drug Administration (FDA) could be beneficial for Hims & hers due to this appointment."
Only 3 Out of 11 Sectors Were Net Bought Last Week – the Largest Notional Short Selling in 5+ Years
JPMorgan Updates Its U.S. Analyst Focus List – Adds TPR, ALRM, REG
(LLY) - Analyzing Eli Lilly's Short Interest
Market Whales and Their Recent Bets on ABBV Options
Hims & Hers up 18% Amid Optimism for Compounders With Makary FDA Pick
Weekly ETF Flows: Nine Out of 11 Sector Funds Record Inflows
Why Is Merck Stock Trading Higher On Monday?
Sector Update: Health Care Stocks Edge Higher Premarket Monday
Leading And Lagging Sectors For November 25, 2024
Abbott Tests New Balloon-Expandable TAVI System for Aortic Stenosis, Launches First Patient Procedures With Investigational TAVI Device
Merck's WINREVAIR Achieves Results in PAH Study, Trial Ends Early on Efficacy
Futu Morning News | Official announcement! Trump nominates Benset to serve as usa Secretary of the Treasury; Goldman Sachs is bullish on US stocks: the s&p 500 will rise to 7000 points.
Goldman Sachs 2025 csi commodity equity index outlook: Long gold is the "Top Trade", oil & gas prices may see a "temporary uptrend"; USA PMI in November hit the fastest level since April 2022, factories increase purchases of imported inputs; USA election settled, consumer confidence lower than expected, long-term inflation expectations breaking through the range top.
WHO Extends Mpox Emergency; Canada Reports First Clade I Case
Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC
Wall Street Makes Steady Gains This Week, as Bitcoin's $100K Race Steals Spotlight
Merck Recommends Rejection Of TRC Capital's "Mini-Tender" Offer To Purchase Up To 1M Shares Of Common Stock At $96.38 Per Share
On CNBC, Jim Lebenthal Announced Bought More AbbVie; Bought More Cisco Systems
Sanofi Becomes Latest Drugmaker to Challenge HHS Over 340B Drug-discount Program
Health Care Sector Had the Most Stocks With 4-week Low and RSI Below 30 Since Spring